Sanofi, WHO Renew Partnership To Finance Research, Other Efforts To Address NTDs

Reuters: Sanofi renews deal with WHO to fight tropical diseases, sleeping sickness
“French healthcare company Sanofi announced on Tuesday a renewal of its partnership with the World Health Organization (WHO) to fight neglected tropical diseases and to eliminate sleeping sickness before 2030. Sanofi said its new five-year commitment with the WHO would see Sanofi provide financial support of $5 million per year over those five years, to finance research and work dedicated to tackling those ailments” (Kar-Gupta, 12/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.